Inovio Rises on Positive Zika Vaccine Results in First Human Study
Inovio Pharmaceuticals shares saw a handy gain on Wednesday after the company reported positive results from its early-stage Zika trial.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 182
Akebia Therapeutics Jumps on License and Collaboration Deal
Akebia Therapeutics shares saw a handy gain on Tuesday after the company reported a new collaboration with Otsuka Pharmaceutical.
Conatus More Than Doubles on Key License Collaboration Agreement
Conatus Pharmaceuticals saw its shares more than double early on Tuesday after the company reported an exclusive collaboration and license agreement for its cirrhosis treatment.
Clovis Wins Key FDA Approval on Ovarian Cancer Treatment
Clovis Oncology, Inc. (NASDAQ: CLVS) is watching its shares hit a new 52-week high after the company reported a key U.S. Food and Drug Administration (FDA) approval. Essentially, the FDA approved Rubraca (rucaparib) tablets…
Portola Pharma Wins on Pfizer and Bristol-Myers Loan Agreement
Portola Pharmaceuticals shares saw a handy gain on Monday after it was reported that the company had received a key loan.
Jefferies 2017 Managed Care Stocks to Buy as Obamacare May Be Repealed
While at the end of the day nobody knows exactly what the final action will be in regards to Obamacare, one thing is for sure: things are going to change at some level.
Syndax Pharma Inks Key Agreement With National Cancer Institute
Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) is watching its shares make a handy gain on Wednesday after the firm reported a key agreement. Essentially, the company announced that it has entered into a Cooperative Research…
TiGenix Updates IPO Terms
TiGenix intends to offer more than 2 million American depositary shares in its initial public offering and to list on the Nasdaq.
Achaogen Prices Secondary Offering
Achaogen has priced its more than 6 million share offering at $13.50 per share in a secondary offering valued up to roughly $101 million.
Vericel Wins on Key FDA Approval
Vericel shares jumped sharply early Wednesday after the company announced that the FDA has approved its treatment of symptomatic cartilage defects of the knee in adults.
Achaogen Gears Up for Secondary Offering
Achaogen, Inc. (NASDAQ: AKAO) saw its shares continue to rise late on Tuesday after the company reported that it would conduct a secondary offering. The company said that it would be offering up to…
Proteon Therapeutics Craters on Missed Late-Stage Results
Proteon Therapeutics saw its shares absolutely crater on Tuesday after the company reported top-line results from its late-stage chronic kidney disease trial.
aTyr Pharma Drops on Clinical Update
aTyr Pharma shares dropped early on Tuesday after the company announced clinical results from its exploratory trials assessing the safety and potential activity of Resolaris.
SCYNEXIS Clinical Update Does Not Ruffle Any Feathers
SCYNEXIS shares remained relatively flat on Tuesday after the company provided a clinical update for its antifungal agent.
Inovalon Holdings Slides on Updated Full-Year Guidance
Inovalon Holdings saw its shares drop early on Tuesday after the company provided an update on its 2016 full-year financial guidance.